STOCK TITAN

Opthea (NASDAQ: OPT) files 6-K on new company secretary appointment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Opthea Limited submitted a Form 6-K as a foreign private issuer, primarily to furnish a press release announcing the appointment of a new company secretary. The report lists this press release as Exhibit 99.1 and is signed on behalf of Opthea by Executive Officer Jeremy Levin.

Positive

  • None.

Negative

  • None.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File No. 001-39621

 

OPTHEA LIMITED

(Translation of registrant’s name into English)

 

Level 4

650 Chapel Street

South Yarra, Victoria, 3141

Australia

(Address of registrant’s principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

 

 

 

 

 

 


 

EXHIBIT INDEX

 

Exhibit

 

Description

99.1

 

Press Release - Appointment of Company Secretary

 

 

 

 

 

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

OPTHEA LIMITED

 

(Registrant)

 

 

 

 

By:

/s/ Jeremy Levin

 

Name:

Jeremy Levin

 

Title:

Executive Officer

 

Date: 10/27/2025

 


FAQ

What did Opthea (OPT) report in this Form 6-K?

Opthea filed a Form 6-K to furnish a press release related to governance. The exhibit describes the appointment of a company secretary, with the report signed on behalf of Opthea by Executive Officer Jeremy Levin.

What is the key corporate action disclosed by Opthea (OPT) in this filing?

The key corporate action is a press release about the appointment of a company secretary. This governance-related update is included as Exhibit 99.1 to the Form 6-K filed by Opthea Limited.

Who signed the Opthea (OPT) Form 6-K report?

The Form 6-K report was signed on behalf of Opthea Limited by Jeremy Levin. He is identified in the document as an Executive Officer authorized to sign for the registrant.

What exhibit is attached to Opthea’s (OPT) October 2025 Form 6-K?

The Form 6-K includes Exhibit 99.1. This exhibit is described as a press release concerning the appointment of a company secretary at Opthea Limited.

Does Opthea (OPT) report under Form 20-F or Form 40-F?

The Form 6-K indicates that Opthea is a foreign issuer that files annual reports under Form 20-F. This aligns with its status as a foreign private issuer reporting under U.S. securities laws.
Opthea Ltd

NASDAQ:OPT

View OPT Stock Overview

OPT Rankings

OPT Latest News

OPT Latest SEC Filings

OPT Stock Data

524.82M
171.00M
Biotechnology
Healthcare
Link
Australia
Melbourne